Highlights

  • Since our initiating report in May 2021, this company has announced plans to go public by listing its shares on the Canadian Securities Exchange (CSE), with cross-listings on the U.S. OTC and the Frankfurt Exchange by mid-2022. This company has entered into a share exchange agreement, with a Special Purpose Vehicle (SPV) for the listing.
            • This report is currently available to premium subscribers – Free subscribers will gain access on December 31st, 2021
              Join as a FREE member and get our research report delivered straight to your inbox, with a seven-day delay

Visit The Diabetes App Inc. page for more research, discussion boards and to like, and share.


Download Analyst Report :